D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Broadcom
AVGO
|
$596M |
| 2 |
Accenture
ACN
|
$470M |
| 3 |
Intel
INTC
|
$412M |
| 4 |
Adobe
ADBE
|
$365M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$258M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$1.5B |
| 2 |
Apple
AAPL
|
$1.02B |
| 3 |
Microsoft
MSFT
|
$776M |
| 4 |
Netflix
NFLX
|
$688M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
$542M |
Sector Composition
| 1 | Technology | 26.84% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Financials | 10.39% |
| 4 | Healthcare | 9.6% |
| 5 | Industrials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Fox Factory Holding Corp
FOXF
$1.22B
| $32.5M | 0.03% |
674,051
+135,542
| +25% | +$6.53M |
|
352
Zoom
ZM
$25B
| $32.5M | 0.03% |
548,731
-1,738,492
| -76% | -$103M |
|
353
National Vision
EYE
$1.86B
| $32.5M | 0.03% |
2,479,245
+1,330,023
| +116% | +$17.4M |
|
354
Warner Music
WMG
$17B
| $32.2M | 0.03% |
1,050,210
+497,102
| +90% | +$15.2M |
|
355
Power Integrations
POWI
$2.52B
| $32.1M | 0.03% |
457,470
+131,735
| +40% | +$9.25M |
|
356
Transmedics
TMDX
$3.55B
| $31.7M | 0.03% |
+210,271
| New | +$31.7M |
|
357
Citizens Financial Group
CFG
$22.3B
| $31.7M | 0.03% |
878,888
+420,404
| +92% | +$15.1M |
|
358
Cooper Companies
COO
$13.5B
| $31.4M | 0.03% |
360,018
+167,061
| +87% | +$14.6M |
|
359
Celldex Therapeutics
CLDX
$1.52B
| $31.3M | 0.03% |
845,560
+272,389
| +48% | +$10.1M |
|
|
SILK
360
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $31.2M | 0.03% |
1,154,781
-444,710
| -28% | -$12M |
|
361
Coca-Cola
KO
$292B
| $31.1M | 0.03% |
488,724
-794,499
| -62% | -$50.6M |
|
362
PROG Holdings
PRG
$1.4B
| $31.1M | 0.03% |
896,075
+6,803
| +0.8% | +$236K |
|
363
IDEAYA Biosciences
IDYA
$2.38B
| $31.1M | 0.03% |
884,538
+226,514
| +34% | +$7.95M |
|
364
Lam Research
LRCX
$130B
| $31M | 0.03% |
291,230
+150,790
| +107% | +$16.1M |
|
365
Cardinal Health
CAH
$35.7B
| $30.9M | 0.03% |
313,926
+102,166
| +48% | +$10M |
|
366
Merus
MRUS
$5.1B
| $30.8M | 0.03% |
521,339
+247,813
| +91% | +$14.7M |
|
367
Corcept Therapeutics
CORT
$7.31B
| $30.8M | 0.03% |
949,143
-183,941
| -16% | -$5.98M |
|
368
Kulicke & Soffa
KLIC
$1.99B
| $30.8M | 0.03% |
625,284
+313,244
| +100% | +$15.4M |
|
369
Affiliated Managers Group
AMG
$6.54B
| $30.6M | 0.03% |
195,756
-41,657
| -18% | -$6.51M |
|
370
Nuvalent
NUVL
$5.83B
| $30.3M | 0.03% |
399,199
-46,183
| -10% | -$3.5M |
|
371
Avidity Biosciences
RNA
$6.48B
| $30.2M | 0.03% |
739,039
+707,773
| +2,264% | +$28.9M |
|
372
Textron
TXT
$14.5B
| $30M | 0.03% |
349,272
-365,278
| -51% | -$31.4M |
|
373
Fluor
FLR
$6.72B
| $30M | 0.03% |
688,388
+38,847
| +6% | +$1.69M |
|
374
Alibaba
BABA
$323B
| $30M | 0.03% |
416,157
+337,313
| +428% | +$24.3M |
|
375
MaxLinear
MXL
$1.36B
| $29.9M | 0.03% |
1,484,324
-91,058
| -6% | -$1.83M |
|